Paraoxonase 1 Ameliorates Renal Lipotoxicity by Activating Lipophagy and Inhibiting Pyroptosis
Related Experiment Video
Updated: Sep 1, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Qing Liu1, Jing-Jie Xiao1, Shan Wang1
1Department of Biochemistry and Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China.
Abstract:
Several studies in recent years have shown that lipid overload causes lipotoxic damage to the kidney, and oxidative stress, inflammation, and autophagic arrest are all important mechanisms of renal lipotoxicity. However, effective measures with therapeutic effects on renal lipotoxicity are limited. The present study indicated the protective effect of the paraoxonase 1 (PON1) against renal lipotoxicity in high-fat diet-fed scavenger receptor class B type I-deficient (SR-BI-/-) mice. The results showed that SR-BI-/- mice exhibited significant renal pathologic characteristics, such as oxidative stress, inflammation, and fibrosis, under a normal chow diet, and were accompanied by dyslipidemia and reduced plasma PON1 activity and renal PON1 levels. PON1 overexpression significantly attenuated the above pathologic changes in the kidneys of SR-BI-/- mice fed with a high-fat diet. Mechanistically, PON1 may ameliorate renal oxidative stress by reducing reactive oxygen species production, reduce renal lipid accumulation by inhibiting AKT/mechanistic target of rapamycin kinase pathway to activate lipophagy, and reduce the occurrence of inflammation and cell death by inhibiting Nod-like receptor family protein 3 inflammasome-mediated pyroptosis. The present study is the first to show that PON1 overexpression can effectively alleviate renal lipotoxicity injury, and PON1 may be a promising therapeutic strategy for the treatment of renal lipotoxicity-related diseases.
Insights
Paraoxonase 1 (PON1) protects kidneys from lipid overload damage. Overexpressing PON1 in scavenger receptor class B type I-deficient mice reduced kidney damage, suggesting PON1 as a potential therapy for kidney lipotoxicity.
Area of Science:
- Nephrology
- Metabolic Diseases
- Biochemistry
Background:
- Lipid overload causes kidney damage through oxidative stress, inflammation, and impaired autophagy.
- Effective treatments for renal lipotoxicity remain limited.
- Scavenger receptor class B type I deficiency (SR-BI-/-) exacerbates kidney pathology.
Purpose of the Study:
- To investigate the protective role of paraoxonase 1 (PON1) against renal lipotoxicity.
- To explore the therapeutic potential of PON1 in a mouse model of kidney lipotoxicity.
Main Methods:
- Utilized high-fat diet-fed SR-BI-/- mice to model renal lipotoxicity.
- Assessed renal pathology, oxidative stress, inflammation, and lipid accumulation.
- Investigated the effect of PON1 overexpression on these parameters.
- Examined underlying molecular mechanisms including AKT/mTOR and NLRP3 inflammasome pathways.
Main Results:
- SR-BI-/- mice showed kidney damage, oxidative stress, inflammation, and fibrosis, with reduced PON1 activity.
- PON1 overexpression significantly ameliorated these pathological changes in high-fat diet-fed SR-BI-/- mice.
- PON1 reduced reactive oxygen species, inhibited AKT/mTOR to promote lipophagy, and suppressed NLRP3 inflammasome-mediated pyroptosis.
Conclusions:
- PON1 demonstrates a significant protective effect against renal lipotoxicity.
- PON1 overexpression alleviates kidney injury by reducing oxidative stress, lipid accumulation, inflammation, and pyroptosis.
- PON1 represents a promising therapeutic target for treating renal lipotoxicity-related diseases.
Related Concept Videos
Peroxisomes
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Catabolism

